This approach attracts visitors who seek reliable information about weight loss
Lemme claims that the product acts to "promote GLP-1 production," reduce hunger and cravings," "promote fat reduction and healthy weight management" on the basis of "three clinically-studied ingredients." If Lemme argues in a motion to dismiss or its Answer that the case should be barred because a private consumer cannot bring a lawsuit based on lack of adequate substantiation, the plaintiffs may argue that "clinically studied" implies "clinically proven" or "clinically shown" and, therefore, may convey that the product has the level of support touted in the advertising
A board-certified family physician possesses the full diagnostic authority to prescribe and manage GLP-1 therapies
The target is metabolic: insulin sensitivity, visceral and liver fat, lipids, the markers of metabolic health rather than a number on the scale
Efficacy and safety of LixiLan, a titratable fixed-ratio combination of Lixisenatide and insulin glargine, versus insulin glargine in type 2 diabetes inadequately controlled on metformin monotherapy: the LixiLan proof-of-concept randomized trial